SCHEMBL8042425

SCHEMBL8042425

COc1ccccc1C1CCN(CCCCN2C(=O)c3ccccc3C2=O)C1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.63
ALDH1A1 P00352 2/20 0.60
HTR1A P08908 2/20 0.60
HTR7 P34969 2/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
ALOX12 P18054 1/20 0.60
ADRA1D P25100 1/20 0.60
ADRA1A P35348 1/20 0.60
ADRA1B P35368 1/20 0.60
HIF1A Q16665 1/20 0.60
HSD17B10 Q99714 1/20 0.60
KDM4E B2RXH2 1/20 0.58
GLA P06280 1/20 0.58
HPGD P15428 1/20 0.58
DRD3 P35462 5/20 0.57
HRH1 P35367 1/20 0.57
HTR2B P41595 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8042421 1.00 DRD2 (0.63) DRD2ALDH1A1HTR1AHTR7MEN1
SCHEMBL6709241 0.82 HTR1A (0.62) DRD2ALDH1A1HTR1AHTR7MEN1
SCHEMBL8043711 0.82 DRD2 (0.61) DRD2MEN1KMT2A
SCHEMBL8043716 0.82 DRD2 (0.61) DRD2MEN1KMT2A
SCHEMBL8045751 0.82 DRD2 (0.61) DRD2MEN1KMT2A
SCHEMBL6710778 0.81 DRD2 (0.58) DRD2ALDH1A1HTR1AHTR7MEN1
SCHEMBL8042443 0.81 GRIN1 (0.61) DRD2HTR1AHTR7MEN1KMT2A
SCHEMBL8042446 0.81 GRIN1 (0.61) DRD2HTR1AHTR7MEN1KMT2A
SCHEMBL8042457 0.80 DRD2 (0.63) DRD2MEN1KMT2A
Hydrochloric Acid SCHEMBL8045698 0.80 GRIN1 (0.60) DRD2HTR1AHTR7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133275-A ALPHA 1 ADRENORECEPTOR ANTAGONISTS; TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER UROLOGICAL DISEASES E.G., BLADDER OUTLET OBSTRUCTION), NEUROGENIC BLADDER AND GYNECOLOGICAL SYNDROMES, E.G., DYSMENORRHEA; UTERINE MUSCLE RELAXANTS ABBOTT LABORATORIES (US) 2000-10-17 US claimed
WO-1999057122-A1 3-PHENYLPYRROLE ALPHA-1 ADRENERGIC COMPOUNDS ABBOTT LABORATORIES (US) 1999-11-11 WO claimed
US-6133275-A ALPHA 1 ADRENORECEPTOR ANTAGONISTS; TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER UROLOGICAL DISEASES E.G., BLADDER OUTLET OBSTRUCTION), NEUROGENIC BLADDER AND GYNECOLOGICAL SYNDROMES, E.G., DYSMENORRHEA; UTERINE MUSCLE RELAXANTS ABBOTT LABORATORIES (US) 2000-10-17 US disclosed
WO-1999057122-A1 3-PHENYLPYRROLE ALPHA-1 ADRENERGIC COMPOUNDS ABBOTT LABORATORIES (US) 1999-11-11 WO disclosed